118 related articles for article (PubMed ID: 26775387)
1. Osteoprotegerin as a marker of atherosclerosis in type 1 and type 2 diabetic patients.
Alkaç C; Alkaç B; Akbaş F; Aral H; Karagöz Y; Altunoğlu EG
Turk J Med Sci; 2015; 45(6):1306-11. PubMed ID: 26775387
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
Ahmed S; Sobh R
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis.
Mogelvang R; Pedersen SH; Flyvbjerg A; Bjerre M; Iversen AZ; Galatius S; Frystyk J; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):515-20. PubMed ID: 22100028
[TBL] [Abstract][Full Text] [Related]
4. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
Grauslund J; Rasmussen LM; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
[TBL] [Abstract][Full Text] [Related]
5. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
[TBL] [Abstract][Full Text] [Related]
6. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
7. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
[TBL] [Abstract][Full Text] [Related]
8. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
Elsamahy MH; Elhenawy YI; Nawar MM
J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
[TBL] [Abstract][Full Text] [Related]
9. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes.
Altinova AE; Toruner F; Akturk M; Bukan N; Yetkin I; Cakir N; Arslan M
Scand J Clin Lab Invest; 2011 Jul; 71(4):340-3. PubMed ID: 21486111
[TBL] [Abstract][Full Text] [Related]
11. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
13. Higher concentrations of osteoprotegerin in type 1 diabetic patients are related to retinopathy: Results from the Poznań Prospective Study.
Grzelka A; Naskręt D; Araszkiewicz A; Uruska A; Wegner M; Zozulińska-Ziółkiewicz D
Adv Clin Exp Med; 2017 Dec; 26(9):1343-1349. PubMed ID: 29442454
[TBL] [Abstract][Full Text] [Related]
14. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
Xiang GD; Sun HL; Zhao LS
Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
[TBL] [Abstract][Full Text] [Related]
15. Carotid intima media thickness and associations with serum osteoprotegerin and s-RANKL in children and adolescents with type 1 diabetes mellitus with increased risk for endothelial dysfunction.
Karavanaki K; Tsouvalas E; Vakaki M; Soldatou A; Tsentidis C; Kaparos G; Augoulea A; Alexandrou A; Lambrinoudaki Ι
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1169-1177. PubMed ID: 30352039
[TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis.
Lin WC; Tsai JP; Lai YH; Lin YL; Kuo CH; Wang CH; Hsu BG
Ren Fail; 2020 Nov; 42(1):131-136. PubMed ID: 31950864
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.
Gannagé-Yared MH; Yaghi C; Habre B; Khalife S; Noun R; Germanos-Haddad M; Trak-Smayra V
Eur J Endocrinol; 2008 Mar; 158(3):353-9. PubMed ID: 18299469
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
Rozas Moreno P; Reyes García R; García-Martín A; Varsavsky M; García-Salcedo JA; Muñoz-Torres M
J Endocrinol Invest; 2013 Jan; 36(1):16-20. PubMed ID: 22391059
[TBL] [Abstract][Full Text] [Related]
19. Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk.
Davenport C; Ashley DT; O'Sullivan EP; Corley BT; Fitzgerald P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
J Hypertens; 2011 Dec; 29(12):2469-75. PubMed ID: 21970938
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin in diabetic osteopathy.
Valentini A; Cianfarani MA; Federici M; Tarantino U; Bertoli A
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):49-55. PubMed ID: 31757570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
